Axsome Therapeutics, Inc. — All Filings
616 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-1/A | S-1/A | 0001047469-15-008199 | Nov 2, 2015 | — |
| CORRESP | — | 0001104659-15-074067 | Oct 29, 2015 | — |
| S-1 | S-1 | 0001047469-15-007821 | Oct 13, 2015 | — |
| CORRESP | — | 0001104659-15-070402 | Oct 13, 2015 | — |
| UPLOAD | — | 0000000000-15-046662 | Sep 22, 2015 | — |
| DRS | — | 0000912057-15-000280 | Aug 25, 2015 | — |
| D | — | 0001579428-15-000002 | May 19, 2015 | — |
| D | — | 0001579428-15-000001 | Jan 7, 2015 | — |
| D | — | 0001579428-14-000001 | Sep 23, 2014 | — |
| D/A | — | 0001579428-13-000004 | Oct 30, 2013 | — |
| D | — | 0001579428-13-000003 | Jul 3, 2013 | — |
| D | — | 0001579428-13-000002 | Jun 19, 2013 | — |